A Data-Driven Workflow for Nanomedicine Optimization Using Active Learning and Automated Experimentation

02 June 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Nanomedicines are an advanced class of drug formulations that hold significant promise, particularly in enhancing the solubility of hydrophobic drugs. However, current state-of-the-art methodologies for developing nanomedicines are often inefficient, limiting both the systematic screening of dosage forms and the fine-tuning of individual formulations. To overcome these challenges, this study introduces a data-driven workflow that integrates active learning with experimental automation to rapidly identify optimal nanoformulations, using aceclofenac as a model poorly soluble drug. The initial formulation design space comprised combinations of the drug with 12 different excipients, resulting in approximately 17 billion possible formulations. To optimize across four objectives simultaneously, the active learning–robotic system efficiently narrowed this vast space to a manageable subset. This refined subset was further explored using a design of experiments approach, with selected formulations manually prepared and subjected to standardized evaluation. Within weeks, a panel of high-performing lead nanoformulations was identified. Notably, several of these promising formulations represent hybrid nanomedicines that are not well studied in the literature. These findings highlight the power of combining AI-driven design with automation to accelerate nanomedicine development and lay the groundwork for more efficient formulation development.

Supplementary materials

Title
Description
Actions
Title
Supplementary information
Description
Supplementary information
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.